Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CBER To Pause Receipt Of Lot Release Samples During Move To White Oak

This article was originally published in The Pink Sheet Daily

Executive Summary

CBER will begin moving to FDA’s main campus about April 25, sooner than initially expected; OGD will relocate about the same time.

Advertisement

Related Content

The Two Towers: US FDA's HQ Expansion Plans Include Office High-Rises, New Conference Center
US FDA Generic Drug Office Director Uhl Announces Retirement
US FDA Generic Drug Office Director Uhl Announces Retirement
FDA Towers At White Oak? High-Rises Could Help Solve Space Problems
US FDA Planning For Possible Doubling Of HQ-Based Staff In 15 Years
FDA Planning For Possible Doubling Of HQ-Based Staff In 15 Years
FDA Faces Budget Crunch In 2023 Under User Fee Legislation
FDA Winding Down White Oak Construction; Outside Rents Going Up
Revising The Blueprint: FDA HQ Construction Nears Completion, But Some Planned Buildings On Hold
FDA FY 2012 Budget Gives Hamburg Regulatory Science Upgrade A Year Late

Topics

Advertisement
UsernamePublicRestriction

Register

PS077083

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel